- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/37 - Factors VIII
Patent holdings for IPC class A61K 38/37
Total number of patents in this class: 665
10-year publication summary
|
50
|
51
|
53
|
62
|
36
|
34
|
37
|
39
|
38
|
23
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bioverativ Therapeutics Inc. | 212 |
55 |
| Takeda Pharmaceutical Company Limited | 2700 |
35 |
| The Children's Hospital of Philadelphia | 874 |
25 |
| CSL Behring GmbH | 348 |
16 |
| CSL Limited | 244 |
16 |
| Octapharma AG | 200 |
16 |
| CSL Behring Lengnau AG | 125 |
16 |
| St. Jude Children's Research Hospital | 234 |
15 |
| Novo Nordisk A/S | 2289 |
13 |
| Quiapeg Pharmaceuticals AB | 38 |
12 |
| BioMarin Pharmaceutical Inc. | 399 |
11 |
| Spark Therapeutics, Inc. | 180 |
11 |
| UCL Business Ltd | 678 |
11 |
| Cantab Biopharmaceuticals Patents Limited | 17 |
10 |
| Rani Therapeutics, LLC | 192 |
10 |
| Sangamo Therapeutics, Inc. | 382 |
10 |
| Baxalta Incorporated | 293 |
9 |
| Emory University | 1727 |
8 |
| Selecta Biosciences, Inc. | 168 |
8 |
| Bayer HealthCare LLC | 1298 |
7 |
| Other owners | 351 |